WB
EVH icon

WesBanco Bank’s Evolent Health EVH Stock Holding History

WesBanco Bank’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-31,328
Closed -$949K – 571
2023
Q2 		$949K Buy
31,328
+11,125
+55% +$360K 0.04% 286
2023
Q1 		$656K Hold
20,203
– – 0.03% 355
2022
Q4 		$567K Buy
+20,203
New +$579K 0.03% 384

Other funds holding EVH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

WesBanco Bank's EVH Position: Q3 2023 in Review

WesBanco Bank sold out of Evolent Health (EVH) in Q3 2023, closing a stake of 31,328 shares — an estimated $949K sold.

WesBanco Bank first reported a position in EVH in Q4 2022 and held it in 3 quarters. The position peaked at $949K in Q2 2023. 203 funds tracked by Wall St. Rank hold EVH as of Q3 2023.

  • WesBanco Bank reported no remaining Evolent Health position as of Q3 2023 after selling out during the quarter.
  • WesBanco Bank sold 31,328 Evolent Health shares in Q3 2023, an estimated $949K.
  • WesBanco Bank first reported a position in Evolent Health in Q4 2022 and held it in 3 quarters.
  • WesBanco Bank's Evolent Health position peaked at $949K in Q2 2023.
  • 203 funds tracked by Wall St. Rank held Evolent Health as of Q3 2023.

Based on WesBanco Bank's 13F filing for Q3 2023, filed 11 Dec 2023.